Salim Hayek Reports Higher Cardiac Risk with Checkpoint Inhibitors

Coverage, in order

1. 1d ago
   
   OncoDaily obscure study

   Salim Hayek Reports Higher Cardiac Risk with Checkpoint Inhibitors

   Salim Hayek, Department Chair of Internal Medicine at The University of Texas Medical Branch, shared on LinkedIn: “Patients on immune checkpoint inhibitors were 40% more likely than patients on chemotherapy

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.